Search Results - "Sulfonamides/adverse effects"
-
1
Authors: et al.
Source: Invest New Drugs
Subject Terms: Male, Adult, Aged, 80 and over, Chromosomes, Human, Pair 14, Sulfonamides, Research, Chromosomes, Human, Pair 11, Multiple myeloma, Aged, 80 and over [MeSH], Aged [MeSH], Bridged Bicyclo Compounds, Heterocyclic/administration, Carfilzomib, Dexamethasone/adverse effects [MeSH], Multiple Myeloma/genetics [MeSH], Sulfonamides/adverse effects [MeSH], Sulfonamides/therapeutic use [MeSH], Male [MeSH], Bridged Bicyclo Compounds, Heterocyclic/therapeutic use [MeSH], Oligopeptides/adverse effects [MeSH], Dexamethasone/administration, Venetoclax, Oligopeptides/therapeutic use [MeSH], Multiple Myeloma/drug therapy [MeSH], Bridged Bicyclo Compounds, Heterocyclic/adverse effects [MeSH], Dexamethasone/therapeutic use [MeSH], Female [MeSH], Adult [MeSH], Translocation, Genetic [MeSH], Dose selection, Humans [MeSH], Chromosomes, Human, Pair 11 [MeSH], Exposure-response, Middle Aged [MeSH], Chromosomes, Human, Pair 14 [MeSH], Sulfonamides/administration, Antineoplastic Combined Chemotherapy Protocols/administration, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Oligopeptides/administration, Relapsed/refractory, Middle Aged, Bridged Bicyclo Compounds, Heterocyclic, Dexamethasone, Translocation, Genetic, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Multiple Myeloma, Oligopeptides, Aged
-
2
Authors: et al.
Contributors: et al.
Source: Journal of Neurosurgery. :1-12
Subject Terms: Male, Vasospasm, Intracranial/diagnostic imaging, Pyridines, Tetrazoles, cerebral ischemia, Brain Ischemia, Dioxanes, 0302 clinical medicine, Vasospasm, Intracranial, Pyridines/administration & dosage, Prospective Studies, Human health sciences, clazosentan, Vasospasm, Intracranial/prevention & control, Pyridines/therapeutic use, Sulfonamides, Subarachnoid Hemorrhage/diagnostic imaging, Anesthesia & intensive care, Middle Aged, Brain Ischemia/etiology, 3. Good health, Dioxanes/therapeutic use, Treatment Outcome, Neurology, Tetrazoles/therapeutic use, endothelin-1, Vasospasm, Intracranial/etiology, Dioxanes/adverse effects, Female, Tetrazoles/adverse effects, Adult, Anesthésie & soins intensifs, subarachnoid hemorrhage, vascular disorders, Sciences de la santé humaine, 03 medical and health sciences, Double-Blind Method, Neurologie, Humans, Pyrimidines/administration & dosage, Pyridines/adverse effects, aneurysm, cerebral vasospasm, Aged, Sulfonamides/administration & dosage, Pyrimidines/adverse effects, Pyrimidines/therapeutic use, Sulfonamides/adverse effects, Sulfonamides/therapeutic use, Subarachnoid Hemorrhage, Vasospasm, Intracranial/drug therapy, Pyrimidines, Subarachnoid Hemorrhage/complications, Surgery, Neurology (clinical), Brain Ischemia/prevention & control
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/39126720
-
3
Authors: et al.
Source: Ann Hematol
Subject Terms: Male, Aged, 80 and over, Sulfonamides, Incidence, Antineoplastic Agents, Middle Aged, Bridged Bicyclo Compounds, Heterocyclic, Antibodies, Monoclonal, Humanized, Leukemia, Lymphocytic, Chronic, B-Cell, 03 medical and health sciences, Antineoplastic Agents/adverse effects [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Bridged Bicyclo Compounds, Heterocyclic/administration, Antibodies, Monoclonal, Humanized/administration, Chronic lymphocytic leukemia, Germany/epidemiology [MeSH], Rituximab/administration, Sulfonamides/adverse effects [MeSH], Original Article, Sulfonamides/therapeutic use [MeSH], Rituximab/therapeutic use [MeSH], Male [MeSH], Bridged Bicyclo Compounds, Heterocyclic/therapeutic use [MeSH], Rituximab/adverse effects [MeSH], Venetoclax, Tumor lysis syndrome, Bridged Bicyclo Compounds, Heterocyclic/adverse effects [MeSH], Female [MeSH], Humans [MeSH], Prospective Studies [MeSH], Real-world evidence, Incidence [MeSH], Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy [MeSH], Middle Aged [MeSH], Sulfonamides/administration, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Antibodies, Monoclonal, Humanized/therapeutic use [MeSH], Antineoplastic Agents/therapeutic use [MeSH], Tumor Lysis Syndrome/etiology [MeSH], Antibodies, Monoclonal, Humanized/adverse effects [MeSH], Austria/epidemiology [MeSH], 0302 clinical medicine, Germany, Austria, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Prospective Studies, Tumor Lysis Syndrome, Rituximab, Aged
-
4
Authors: et al.
Contributors: et al.
Source: Journal of Neurosurgery, 142 (1), 98 - 109 (2025-01-01)
Subject Terms: aneurysm, cerebral ischemia, cerebral vasospasm, clazosentan, endothelin-1, subarachnoid hemorrhage, vascular disorders, Pyridines, Dioxanes, Pyrimidines, Sulfonamides, Tetrazoles, Humans, Male, Middle Aged, Female, Double-Blind Method, Aged, Prospective Studies, Treatment Outcome, Adult, Vasospasm, Intracranial/etiology, Vasospasm, Intracranial/prevention & control, Vasospasm, Intracranial/drug therapy, Vasospasm, Intracranial/diagnostic imaging, Subarachnoid Hemorrhage/complications, Subarachnoid Hemorrhage/diagnostic imaging, Pyridines/therapeutic use, Pyridines/adverse effects, Pyridines/administration & dosage, Dioxanes/therapeutic use, Dioxanes/adverse effects, Pyrimidines/therapeutic use, Pyrimidines/adverse effects, Pyrimidines/administration & dosage, Brain Ischemia/prevention & control, Brain Ischemia/etiology, Sulfonamides/therapeutic use, Sulfonamides/adverse effects, Sulfonamides/administration & dosage, Tetrazoles/therapeutic use, Tetrazoles/adverse effects, Brain Ischemia, Vasospasm, Intracranial, Surgery, Neurology (clinical), Human health sciences, Neurology, Anesthesia & intensive care, Sciences de la santé humaine, Neurologie, Anesthésie & soins intensifs
Relation: https://thejns.org/view/journals/j-neurosurg/aop/article-10.3171-2024.4.JNS232191/article-10.3171-2024.4.JNS232191.xml; urn:issn:0022-3085; urn:issn:1933-0693
Access URL: https://orbi.uliege.be/handle/2268/328394
-
5
Authors: et al.
Source: BMC Cancer
BMC Cancer, Vol 23, Iss S1, Pp 1-11 (2024)Subject Terms: PD-L1, Male, Adult, Urologic Neoplasms, Double-Blind Method [MeSH], Urothelial carcinoma, Aged, 80 and over [MeSH], Aged [MeSH], PD1, Antibodies, Monoclonal, Humanized/administration, Urinary tract neoplasms, IDO1, Cisplatin/adverse effects [MeSH], Carcinoma, Transitional Cell/pathology [MeSH], Sulfonamides/adverse effects [MeSH], Cisplatin/therapeutic use [MeSH], Sulfonamides/therapeutic use [MeSH], Male [MeSH], Randomized controlled study, Immune checkpoint inhibition, Carcinoma, Transitional Cell/drug therapy [MeSH], Indoleamine-Pyrrole 2,3,-Dioxygenase/antagonists, Female [MeSH], Urologic Neoplasms/drug therapy [MeSH], Adult [MeSH], Cisplatin/administration, Humans [MeSH], Middle Aged [MeSH], Sulfonamides/administration, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Epacadostat, Research, Antibodies, Monoclonal, Humanized/therapeutic use [MeSH], Immunotherapy, Urothelium/pathology [MeSH], Urologic Neoplasms/pathology [MeSH], Oximes [MeSH], Antibodies, Monoclonal, Humanized/adverse effects [MeSH], Indoleamine-Pyrrole 2,3,-Dioxygenase/metabolism [MeSH], Pembrolizumab, Antibodies, Monoclonal, Humanized, SDG 3 - Good Health and Well-being, Double-Blind Method, Antineoplastic Combined Chemotherapy Protocols, Oximes, Humans, Indoleamine-Pyrrole 2,3,-Dioxygenase, 10. No inequality, RC254-282, Aged, Aged, 80 and over, Sulfonamides, Carcinoma, Transitional Cell, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, 16. Peace & justice, 3. Good health, Female, Cisplatin
-
6
Authors: et al.
Source: Br J Haematol
British journal of haematology, vol. 197, no. 6, pp. 766-790Subject Terms: Sulfonamides, 03 medical and health sciences, Platelets, Thrombosis and Haemostasis, 0302 clinical medicine, Heparin, Pipecolic Acids, Anticoagulants, Humans, Anticoagulants/adverse effects, Arginine/analogs & derivatives, Heparin/adverse effects, Pipecolic Acids/therapeutic use, Retrospective Studies, Sulfonamides/adverse effects, Thrombocytopenia/chemically induced, Thrombocytopenia/drug therapy, anticoagulation, argatroban, argatroban monitoring, heparin-induced thrombocytopenia, plasmatic argatroban concentration, Arginine, Thrombocytopenia
File Description: application/pdf
-
7
Authors: et al.
Contributors: et al.
Source: Prostate Cancer Prostatic Dis
Subject Terms: Male, Aged, 80 and over, Sulfonamides, Antineoplastic Agents, Middle Aged, 3121 Internal medicine, 3126 Surgery, anesthesiology, intensive care, radiology, Brief Communication, Androgen Receptor Antagonists/therapeutic use [MeSH], Antineoplastic Agents/adverse effects [MeSH], Prostatic Neoplasms, Castration-Resistant/pathology [MeSH], Aged, 80 and over [MeSH], Pyrazoles/adverse effects [MeSH], Aged [MeSH], Antineoplastic Agents/administration, Pyrazoles/therapeutic use [MeSH], 692/699/67/1059, Sulfonamides/adverse effects [MeSH], Sulfonamides/therapeutic use [MeSH], Male [MeSH], 692/699/67/589/466, Androgen Receptor Antagonists/administration, Androgen Receptor Antagonists/adverse effects [MeSH], Humans [MeSH], Neoplasm Metastasis [MeSH], Treatment Outcome [MeSH], Prostatic Neoplasms, Castration-Resistant/drug therapy [MeSH], Middle Aged [MeSH], Sulfonamides/administration, Pyrazoles/administration, Antineoplastic Agents/therapeutic use [MeSH], brief-communication, Odm-201, 3. Good health, Prostatic Neoplasms, Castration-Resistant, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Androgen Receptor Antagonists, Humans, Pyrazoles, Neoplasm Metastasis, Cancers, Phase-1, Aged
File Description: application/pdf; fulltext
-
8
Authors: et al.
Source: Clin Sci (Lond)
Østergaard, J A, Jha, J C, Sharma, A, Dai, A, Choi, J S Y, De Haan, J B, Cooper, M E & Jandeleit-Dah, K 2022, 'Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease', Clinical Science, vol. 136, no. 2, pp. 167-180. https://doi.org/10.1042/CS20210865Subject Terms: Male, 0301 basic medicine, Inflammasomes, Mice, Knockout, ApoE, Oxidative Stress/drug effects, Diabetes Mellitus, Experimental, Furans/adverse effects, Mice, 03 medical and health sciences, Indenes/adverse effects, Inflammation/drug therapy, NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Diabetic Nephropathies, Furans, Diabetic Nephropathies/pathology, Diabetes & Metabolic Disorders, Inflammation, Sulfonamides, 0303 health sciences, Inflammasomes/drug effects, Sulfonamides/adverse effects, Fibrosis, 3. Good health, Oxidative Stress, Indenes, NLR Family, Pyrin Domain-Containing 3 Protein/drug effects
File Description: application/pdf
-
9
Authors: et al.
Source: World J Urol
Subject Terms: Male, Sulfonamides, Indazoles, Aspartate Aminotransferases/analysis [MeSH], Neoplasm Grading [MeSH], Sorafenib/administration, Cytoreduction Surgical Procedures/methods [MeSH], Alanine Transaminase/blood [MeSH], De ritis ratio, Kidney Neoplasms/pathology [MeSH], Sulfonamides/adverse effects [MeSH], Original Article, Neoplasm Staging [MeSH], Nephrectomy/methods [MeSH], Male [MeSH], Tumor markers, Metastatic renal cell carcinoma, Sunitinib/administration, Carcinoma, Renal Cell/blood [MeSH], Karnofsky Performance Status [MeSH], Protein Kinase Inhibitors/adverse effects [MeSH], Aspartate Aminotransferases/blood [MeSH], Female [MeSH], Prognostic marker, Alanine Transaminase/analysis [MeSH], Humans [MeSH], Protein Kinase Inhibitors/administration, Kidney Neoplasms/surgery [MeSH], Sorafenib/adverse effects [MeSH], Survival Analysis [MeSH], Predictive Value of Tests [MeSH], Pyrimidines/administration, Middle Aged [MeSH], Kidney Neoplasms/blood [MeSH], Sulfonamides/administration, Tyrosine-kinase inhibitors, Indazoles/administration, Kidney Neoplasms/drug therapy [MeSH], Carcinoma, Renal Cell/drug therapy [MeSH], Prognosis [MeSH], Pyrimidines/adverse effects [MeSH], Indazoles/adverse effects [MeSH], Sunitinib/adverse effects [MeSH], Carcinoma, Renal Cell/pathology [MeSH], Carcinoma, Renal Cell/surgery [MeSH], Alanine Transaminase, Cytoreduction Surgical Procedures, Middle Aged, Sorafenib, Prognosis, Nephrectomy, Kidney Neoplasms, 3. Good health, 03 medical and health sciences, Pyrimidines, 0302 clinical medicine, Predictive Value of Tests, Humans, Female, Aspartate Aminotransferases, Karnofsky Performance Status, Neoplasm Grading, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Neoplasm Staging
Access URL: https://link.springer.com/content/pdf/10.1007/s00345-021-03628-2.pdf
https://pubmed.ncbi.nlm.nih.gov/33649869
https://link.springer.com/article/10.1007/s00345-021-03628-2
https://www.ncbi.nlm.nih.gov/pubmed/33649869
https://link.springer.com/content/pdf/10.1007/s00345-021-03628-2.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405478
https://repository.publisso.de/resource/frl:6451125 -
10
Authors: et al.
Source: Mobaraki, S, Nissen, P H, Donskov, F, Wozniak, A, Van Herck, Y, Coosemans, L, van Nieuwenhuyse, T, Lambrechts, D, Bechter, O, Baldewijns, M, Roussel, E, Laenen, A & Beuselinck, B 2024, 'Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 Polymorphism', Clinical Genitourinary Cancer, vol. 22, no. 5, 102180. https://doi.org/10.1016/j.clgc.2024.102180
Subject Terms: Male, Adult, Indazoles, Renal Cell/drug therapy, Axitinib, Genotype, Pyridines, Bilirubin/blood, Genetic, 80 and over, Humans, Anilides, Polymorphism, Glucuronosyltransferase, Carcinoma, Renal Cell, Pyridines/therapeutic use, Indazoles/therapeutic use, Anilides/therapeutic use, Hyperbilirubinemia, Aged, Aged, 80 and over, Hyperbilirubinemia/chemically induced, Sulfonamides, Polymorphism, Genetic, Pazopanib, Glucuronosyltransferase/genetics, Hepatotoxicity, Carcinoma, Pyrimidines/therapeutic use, Sulfonamides/adverse effects, Bilirubin, Middle Aged, Renal cell carcinoma, Kidney Neoplasms, 3. Good health, Kidney Neoplasms/drug therapy, Pyrimidines, Axitinib/therapeutic use, Female, Pharmacogenomics
Access URL: https://pubmed.ncbi.nlm.nih.gov/39155162
-
11
Authors: et al.
Contributors: et al.
Source: Ann Hematol
Subject Terms: Medizin, Kaplan-Meier Estimate, Decitabine, Leukocyte Count, 03 medical and health sciences, 0302 clinical medicine, Recurrence, Germany, Antineoplastic Combined Chemotherapy Protocols, Humans, Allografts [MeSH], Bridged Bicyclo Compounds, Heterocyclic/administration, DNA Methylation/drug effects [MeSH], DLI, Febrile Neutropenia/chemically induced [MeSH], Myelodysplastic Syndromes/therapy [MeSH], Azacitidine/administration, Salvage Therapy/adverse effects [MeSH], Leukocyte Count [MeSH], Germany/epidemiology [MeSH], Febrile Neutropenia/blood [MeSH], Sulfonamides/adverse effects [MeSH], Original Article, Decitabine/pharmacology [MeSH], Myelodysplastic Syndromes/drug therapy [MeSH], Venetoclax, Thrombocytopenia/chemically induced [MeSH], Combined Modality Therapy [MeSH], Leukemia, Myeloid, Acute/therapy [MeSH], Relapse, Thrombocytopenia/blood [MeSH], Bridged Bicyclo Compounds, Heterocyclic/adverse effects [MeSH], Transplantation Conditioning [MeSH], Drug Evaluation [MeSH], Hypomethylating agents, Kaplan-Meier Estimate [MeSH], Humans [MeSH], Azacitidine/pharmacology [MeSH], Hematopoietic Stem Cell Transplantation [MeSH], Retrospective Studies [MeSH], Allogeneic hematopoietic stem cell transplantation, Sulfonamides/administration, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Recurrence [MeSH], Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Azacitidine, Azacitidine/adverse effects [MeSH], Decitabine/administration, Immunosuppressive Agents/therapeutic use [MeSH], Leukemia, Myeloid, Acute/drug therapy [MeSH], Tumor Lysis Syndrome/etiology [MeSH], Immunosuppressive Agents/adverse effects [MeSH], Decitabine/adverse effects [MeSH], Febrile Neutropenia, Retrospective Studies, Salvage Therapy, ddc:610, Hematopoietic Stem Cell Transplantation, DNA Methylation, Allografts, Bridged Bicyclo Compounds, Heterocyclic, Combined Modality Therapy, 3. Good health, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Drug Evaluation, Immunosuppressive Agents
File Description: application/pdf
Access URL: https://europepmc.org/articles/pmc8448702?pdf=render
https://pubmed.ncbi.nlm.nih.gov/33191481
https://www.ncbi.nlm.nih.gov/pubmed/33191481
https://link.springer.com/content/pdf/10.1007/s00277-020-04321-x.pdf
https://pubmed.ncbi.nlm.nih.gov/33191481/
https://europepmc.org/article/MED/34160650
https://link.springer.com/article/10.1007/s00277-020-04321-x
https://repository.publisso.de/resource/frl:6467026 -
12
Authors: et al.
Source: Clin Pharmacol Ther
Clinical pharmacology and therapeutics, vol. 109, no. 3, pp. 746-753Subject Terms: Adult, Endothelin Receptor Antagonists, Male, Sulfonamides, Cross-Over Studies, Research, Glycopeptides, Administration, Oral, Natriuresis, Sodium, Dietary, Middle Aged, Water-Electrolyte Balance, Healthy Volunteers, Uric Acid, 3. Good health, 03 medical and health sciences, Pyrimidines, 0302 clinical medicine, Body Water, Double-Blind Method, Homeostasis, Humans, Aldosterone, Switzerland, Aldosterone/blood, Body Water/metabolism, Endothelin Receptor Antagonists/administration & dosage, Endothelin Receptor Antagonists/adverse effects, Glycopeptides/blood, Natriuresis/drug effects, Pyrimidines/administration & dosage, Pyrimidines/adverse effects, Sodium, Dietary/adverse effects, Sulfonamides/administration & dosage, Sulfonamides/adverse effects, Uric Acid/blood, Water-Electrolyte Balance/drug effects, Weight Gain/drug effects, Young Adult
File Description: application/pdf
Access URL: https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2043
https://pubmed.ncbi.nlm.nih.gov/32897570
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984323
https://serval.unil.ch/en/notice/serval:BIB_1BE20415C0D5
https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2043
https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2043
https://serval.unil.ch/notice/serval:BIB_1BE20415C0D5
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_1BE20415C0D58
https://serval.unil.ch/resource/serval:BIB_1BE20415C0D5.P001/REF.pdf -
13
Authors: et al.
Source: Ann Hematol
Annals of HematologySubject Terms: Adult, Aged, 80 and over, Male, 0301 basic medicine, Sulfonamides, 0303 health sciences, Cytarabine, Antineoplastic Agents, Middle Aged, Bridged Bicyclo Compounds, Heterocyclic, Decitabine, 3. Good health, Leukemia, Myeloid, Acute, 03 medical and health sciences, Risk Factors, Azacitidine, Humans, Female, Bridged Bicyclo Compounds, Heterocyclic/adverse effects [MeSH], Female [MeSH], Antineoplastic Agents/adverse effects [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Bridged Bicyclo Compounds, Heterocyclic/administration, Adult [MeSH], Cytarabine/therapeutic use [MeSH], Azacitidine/therapeutic use [MeSH], Humans [MeSH], Middle Aged [MeSH], Risk Factors [MeSH], Letter to the Editor, Oncology, Sulfonamides/administration, Decitabine/therapeutic use [MeSH], Hematology, Sulfonamides/adverse effects [MeSH], Male [MeSH], Antineoplastic Agents/therapeutic use [MeSH], Leukemia, Myeloid, Acute/drug therapy [MeSH], Leukemia, Myeloid, Acute/physiopathology [MeSH], Tumor Lysis Syndrome/etiology [MeSH], Tumor Lysis Syndrome, Aged
Access URL: https://link.springer.com/content/pdf/10.1007/s00277-020-04181-5.pdf
https://pubmed.ncbi.nlm.nih.gov/32705308
https://www.ncbi.nlm.nih.gov/pubmed/32705308
https://pubmed.ncbi.nlm.nih.gov/32705308/
https://link.springer.com/article/10.1007/s00277-020-04181-5
https://link.springer.com/content/pdf/10.1007/s00277-020-04181-5.pdf
https://europepmc.org/article/PMC/PMC7817590
https://repository.publisso.de/resource/frl:6466988 -
14
Authors:
Subject Terms: Anti-Inflammatory Agents, Non-Steroidal/adverse effects, Non-Steroidal/therapeutic use, Arthritis, Rheumatoid/drug therapy, Aspirin/adverse effects, Aspirin/therapeutic use, Cardiovascular Diseases/chemically induced, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/mortality, Celecoxib, Clinical Trials as Topic, Cyclooxygenase Inhibitors/adverse effects, Cyclooxygenase Inhibitors/therapeutic use, Humans, Lactones/adverse effects, Lactones/therapeutic use, Osteoarthritis/drug therapy, Pyrazoles, Risk Factors, Sulfonamides/adverse effects, Sulfonamides/therapeutic use, Sulfones
Relation: Expert Opinion on Drug Safety; https://iris.unil.ch/handle/iris/89430; serval:BIB_25296
Availability: https://iris.unil.ch/handle/iris/89430
-
15
Authors: et al.
Subject Terms: Aged Aged, 80 and over Carbonic Anhydrase Inhibitors/*adverse effects/therapeutic use Conjunctiva/*drug effects/pathology Conjunctivitis/*chemically induced/pathology Female Glaucoma, Angle-Closure/drug therapy Humans Male Ocular Hypertension/drug therapy Ophthalmic Solutions/adverse effects/therapeutic use Sulfonamides/*adverse effects/therapeutic use Thiophenes/*adverse effects/therapeutic use
Relation: Archives of ophthalmology; https://iris.unil.ch/handle/iris/64348; serval:BIB_14836574EB53; 000083055700025
Availability: https://iris.unil.ch/handle/iris/64348
-
16
Authors: et al.
Subject Terms: Adolescent Adult Cyclooxygenase Inhibitors/*therapeutic use Double-Blind Method Female Humans Indomethacin/adverse effects Obstetric Labor, Premature/*drug therapy Pregnancy Prospective Studies Pyrazoles Sulfonamides/*adverse effects Tocolytic Agents/*adverse effects
Relation: American Journal of Obstetrics & Gynecology; https://iris.unil.ch/handle/iris/36441; serval:BIB_0773C8DFC063; 000178256400023
-
17
Authors: et al.
Subject Terms: Administration, Topical, Adult, Carbonic Anhydrase Inhibitors/pharmacokinetics, Double-Blind Method, Half-Life, Humans, Male, Prospective Studies, Sulfonamides/administration & dosage, Sulfonamides/adverse effects, Thiophenes/administration & dosage, Thiophenes/adverse effects
Relation: European Journal of Clinical Pharmacology; https://iris.unil.ch/handle/iris/183424; serval:BIB_9C877F5F9C94; A1995QE32900013; 7720769
Availability: https://iris.unil.ch/handle/iris/183424
-
18
Authors: et al.
Subject Terms: Aged, Alanine Transaminase/blood, Angiogenesis Inhibitors/adverse effects, Antineoplastic Agents/adverse effects, Carcinoma, Renal Cell/drug therapy, Renal Cell/enzymology, Female, Genes, MHC Class I, MHC Class II, Genetic Markers, Histocompatibility Antigens Class I/genetics, Humans, Kidney Neoplasms/drug therapy, Kidney Neoplasms/enzymology, Male, Membrane Proteins/genetics, Middle Aged, Pharmacogenetics, Polymorphism, Single Nucleotide, Pyrimidines/adverse effects, Sulfonamides/adverse effects
Relation: Journal of Hepatology; https://iris.unil.ch/handle/iris/157389; serval:BIB_88E2F3B51D6F; 000291523000022
-
19
Authors: et al.
Subject Terms: Adult Anti-Inflammatory Agents, Non-Steroidal/*adverse effects Dinoprostone/urine Drug Interactions Electrolytes/metabolism Furosemide/pharmacokinetics/*pharmacology Hemodynamic Processes/drug effects Humans Kidney/*drug effects/physiology Male Sulfonamides/*adverse effects
Relation: Drugs; https://iris.unil.ch/handle/iris/100543; serval:BIB_586429A0C781; 7506186
Availability: https://iris.unil.ch/handle/iris/100543
-
20
Authors: et al.
Source: Circulation
Circulation, Vol. 139, No 1 (2019) pp. 51-63Subject Terms: Male, macitentan, Time Factors, Down syndrome, EXERCISE CAPACITY, PULMONARY-ARTERIAL-HYPERTENSION, BOSENTAN THERAPY, DOUBLE-BLIND, 0302 clinical medicine, Antihypertensive Agents/adverse effects/therapeutic use, pulmonary arterial hypertension, Original Research Articles, Pulmonary Artery/drug effects/physiopathology, Child, Aged, 80 and over, 2. Zero hunger, Exercise Tolerance/drug effects, ddc:618, Down Syndrome/complications, congenital heart disease, Eisenmenger syndrome, endothelin receptor antagonist, Adolescent, Adult, Aged, Antihypertensive Agents, Biomarkers, Double-Blind Method, Down Syndrome, Eisenmenger Complex, Endothelin Receptor Antagonists, Exercise Tolerance, Female, Hemodynamics, Humans, Hypertension, Pulmonary, Middle Aged, Natriuretic Peptide, Brain, Peptide Fragments, Pulmonary Artery, Pyrimidines, Recovery of Function, Sulfonamides, Treatment Outcome, Walk Test, Young Adult, 16. Peace & justice, 3. Good health, CONGENITAL HEART-DISEASE, SILDENAFIL, SURVIVAL, Sulfonamides/adverse effects/therapeutic use, Endothelin Receptor Antagonists/adverse effects/therapeutic use, Eisenmenger Complex/complications/diagnostic imaging/physiopathology, TREPROSTINIL, Pyrimidines/adverse effects/therapeutic use, 03 medical and health sciences, INHALED ILOPROST, EFFICACY, Hypertension, Pulmonary/diagnostic imaging/drug therapy/etiology/physiopathology, Hemodynamics/drug effects, Natriuretic Peptide, Brain/blood, Peptide Fragments/blood, Biomarkers/blood
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/30586694/
https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2Fe9ba09bc-a8f8-4606-88f0-c16b86c61015
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314514/
https://archive-ouverte.unige.ch/unige:134639/ATTACHMENT01
https://www.rug.nl/research/portal/files/73993713/Evaluation_of_Macitentan_in_Patients_With_Eisenmenger_Syndrome.pdf
https://europepmc.org/article/MED/30586694
https://archive-ouverte.unige.ch/unige:134639
Full Text Finder 
Nájsť tento článok vo Web of Science 
Full Text